Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The University of Delhi has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. Prosecution for this portfolio involves 1 distinct examiner and 1 distinct art unit. This suggests a targeted approach to patenting academic research within the life sciences domain, focusing on a specific technological niche that falls under the jurisdiction of a single USPTO administrative group.
JERICA KATLYNN WILSON is the busiest examiner for the university, managing 1 pending office action. With only 1 distinct examiner and 1 distinct art unit, the university's current patenting efforts are concentrated in a single area of the USPTO. The 1 pending office action represents the entirety of the university's active prosecution pipeline in this specific technology area. This centralized prosecution model means that the university's immediate intellectual property outcomes are highly dependent on the individual examination practices and timelines of the 1 distinct examiner currently assigned to the matter.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILSON, JERICA KATLYNN | 1 | 61.4% | +39.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18013155 | COMPOUNDS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | WILSON, JERICA KATLYNN | 19d overdue |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18013155 | COMPOUNDS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | WILSON, JERICA KATLYNN | 1621 | §103 | Final Rejection | 19d overdue | Pending | Dec 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial